MedPath

Optical Coherence Tomography - Guided Protocol for Left Main Percutaneous Coronary Intervention

Not Applicable
Completed
Conditions
Left Main Coronary Artery Stenosis
Interventions
Other: standardised OCT-guided intervention
Registration Number
NCT04248777
Lead Sponsor
Institut Mutualiste Montsouris
Brief Summary

LEMON aim is to evaluate the feasibility, efficiency and security of a standardized Optical Coherence Tomography (OCT) - guided protocol for completion and optimization of Left Main (LM) Percutaneous Coronary Intervention (PCI).

Detailed Description

The LEMON study (LEft Main Oct-guided iNterventions) is a prospective, multicentre, open-label, interventional , non-randomized trial that investigates the feasibility and efficiency of OCT guidance for left main PCI in 10 active French interventional cardiology centres. The aim of the study is the appliance of a pre-defined standardized protocol for LM PCI . The LM PCI strategy is guided by 3 OCT runs, according to a pre-determined protocol. The first OCT run (run1) is performed before any stent implantation, the second run (run2) is performed after the stent is implanted, POT (proximal optimization technique) is applied and side branch iss rewired through stent struts. The third run (run3) is performed after PCI optimization. In case of additional stent optimization, a supplementary OCT run is applied in order to assess final result.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
71
Inclusion Criteria
  • age >18
  • stable or non-stable distal Left Main lesion (with or without previous Coronary Artery Bypass Graft), involving or not Left Anterior Descending and Coronary Circumflex ostias and requiring Percutaneous Coronary Intervention with a one or two stents strategy
  • stable or non-stable ostial Left Anterior Descending and/or Coronary Circumflex lesion requiring Percutaneous Coronary Intervention with involvement of distal Left Main
  • SYNTAX angiographic score <23
  • informed consent
Exclusion Criteria
  • ostial Left Main lesion
  • on-going acute STEMI
  • on-going cardiogenic shock
  • severe chronic renal failure (Cr Cl <30 ml/min/m2)
  • anticipated technical contra-indication to OCT (highly calcified lesions, severe proximal tortuosity)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
left main PCI guided by OCTstandardised OCT-guided interventionThe LM PCI strategy is guided by 3 OCT runs, according to a pre-defined standardized protocol.
Primary Outcome Measures
NameTimeMethod
success of the OCT procedurePost PCI / Immediate

score Thrombolysis In Myocardial Infarction (TIMI) equal to 3 in all vessels, 50% residual stenosis in the various angiography segments, adequate expansion according to minimum intra stent area \> 80% of the luminal area of the reference segment on Main Vessel and Main Branch.

Secondary Outcome Measures
NameTimeMethod
incidence of major adverse cardiovascular events30 days post PCI

death, cardiovascular death, stent thrombosis, target vessel revascularization

rate of appropriate wire position30 days post PCI

percentage of appropriate wire position in adequate stent cell before side branch ostium dilation.

rate of appropriate stent expansion according to DOCTORS and ILUMIEN-III criteria.30 days post PCI

percentage of stent expansion according to DOCTORS and ILUMIEN-III

Trial Locations

Locations (11)

Clinique Saint Augustin

🇫🇷

Bordeaux, France

Chu Besancon

🇫🇷

Besancon, France

Ch Chartres

🇫🇷

Le Coudray, France

Chu Bordeaux

🇫🇷

Bordeaux, France

Hôpital privé Saint Martin

🇫🇷

Caen, France

Institut hospitalier Jacques Cartier

🇫🇷

Massy, France

Clinique Saint Hilaire

🇫🇷

Rouen, France

CHU Nîmes

🇫🇷

Nîmes, France

Institut Mutualiste Montsouris

🇫🇷

Paris, France

Chu Clermont Ferrand

🇫🇷

Clermont Ferrand, France

Ch Annecy Genevois

🇫🇷

Metz-Tessy, France

© Copyright 2025. All Rights Reserved by MedPath